Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Federowicz

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Transfusion|January 1, 1996
Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storageI Federowicz, B B Barrett, J W Andersen, et al.
British Journal of Cancer|September 24, 2014
Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL studyE Van Cutsem, C-P Li, E Nowara, et al.
Bone Marrow Transplantation|September 12, 2007
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplantB Nasilowska-Adamska, P Rzepecki, J Manko, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Transfusion|January 1, 1996
Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storageI Federowicz, B B Barrett, J W Andersen, et al.
British Journal of Cancer|September 24, 2014
Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL studyE Van Cutsem, C-P Li, E Nowara, et al.
Bone Marrow Transplantation|September 12, 2007
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplantB Nasilowska-Adamska, P Rzepecki, J Manko, et al.
Pageof 1